A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
New England Journal of Medicine · 19.06.2025 · 392 (23) · 2309-2320
DOI: 10.1056/nejmoa2501561 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 19.06.2025. Verfasst von Richard J Nowak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Yale University, New Haven, CT. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Myasthenia Gravis. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Amgen Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Yale University, New Haven, CT.
- University of Miami Miller School of Medicine, Miami.
- University of Rochester, Rochester, NY.
- University of North Carolina, Chapel Hill.
- University of Oxford, Oxford, United Kingdom.
- Hanamaki General Hospital, Hanamaki, Japan.
ORCID-Profile: Michael Benatar, John Vissing
Förderung
- Amgen Inc.
Zitieren
APA
Nowak, R. J., Benatar, M., Ciafaloni, E., Howard, J. F., Leite, M. I., Utsugisawa, K., Vissing, J., Rojavin, M., Li, Q., Tang, F., Wu, Y., Rampal, N., Cheng, S., & MINT Investigators (2025). A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis. New England Journal of Medicine, 392(23), 2309-2320. https://doi.org/10.1056/nejmoa2501561
Vancouver
Nowak RJ, Benatar M, Ciafaloni E, Howard JF, Leite MI, Utsugisawa K, et al. A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis. New England Journal of Medicine. 2025;392(23):2309-2320. doi:10.1056/nejmoa2501561
BibTeX
@article{Nowak2025,
author = {Nowak, Richard J and Benatar, Michael and Ciafaloni, Emma and Howard, James F and Leite, M Isabel and Utsugisawa, Kimiaki and Vissing, John and Rojavin, Mikhail and Li, Qing and Tang, Fengming and Wu, Yanping and Rampal, Nishi and Cheng, Sue and MINT Investigators, MINT Investigators},
title = {A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {23},
pages = {2309--2320},
doi = {10.1056/nejmoa2501561}
}
EUVIMED